US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

BusPIRone Hydrochloride Tablets USP 7.5 mg

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-201-01 D-0375-2023
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets USP

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-044-15 D-0371-2023
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-283-10 D-0370-2023
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-282-10 D-0369-2023
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-281-10 D-0368-2023
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-280-10 D-0367-2023
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-279-10 D-0366-2023
Class II · Moderate risk Terminated

Aripiprazole Tablets

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-278-10 D-0365-2023
Class II · Moderate risk Terminated

Levothyroxine Sodium Tablets

Reason Sub-Potent Drug: Out of specification for assay at the 24 month interval.

Alvogen, Inc NDC 47781-654-90 D-0353-2023
Class II · Moderate risk Terminated

Abelcet

Reason Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.

Leadiant Biosciences, Inc. NDC 57665-101-41 D-0327-2023
Class III · Low risk Terminated

Dermoplast FIRST AID ANTIBACTERIAL SPRAY

Reason Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.

Advantice Health, Llc NDC 16864-670-01 D-0329-2023
Class III · Low risk Terminated

Bd-102 Nf

Reason Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

DuPont Nutrition USA, Inc D-0352-2023
Class III · Low risk Terminated

Avicel PH-200 NF

Reason Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

DuPont Nutrition USA, Inc D-0351-2023
Class III · Low risk Terminated

Avicel PH- 102 NF

Reason Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

DuPont Nutrition USA, Inc D-0350-2023
Class III · Low risk Terminated

Avicel PH- 101 NF

Reason Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

DuPont Nutrition USA, Inc D-0349-2023
Class II · Moderate risk Terminated

Posaconazole Delayed-Release Tablets

Reason Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.

Biocon Pharma INC NDC 70377-038-11 D-0268-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0160-5 D-0345-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0150-5 D-0344-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0145-5 D-0343-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0135-5 D-0342-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0125-5 D-0341-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0120-5 D-0340-2023